Neurotic depression: approaches to treatment

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Volel' B.A.

Pervyĭ MGMU im. I.M. Sechenova Minzdrava Rossii, Moskva

Sorokina O.Yu.

Mental Health Research Center, Moscow, Russia

Neurotic depression: approaches to treatment

Authors:

Volel' B.A., Sorokina O.Yu.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1‑2): 69‑74

DOI: 10.17116/jnevro20191191269

Read: 14835 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Volel' BA, Sorokina OYu. Neurotic depression: approaches to treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1‑2):69‑74. (In Russ.)
https://doi.org/10.17116/jnevro20191191269

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Associations of polymorphic variants of CYP2C19*2, *17 with effectiveness and safety of sertraline in adolescents with a depressive episode and suicidal tendencies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):12-20

Neuropathic pain in chronic inflammatory demyelinating polyneuropathies: analysis of 64 cases. Russian Journal of Pain. 2025;(2):45-53

Effect of polymorphic variants of the HTR2A gene on the effectiveness and safety of sertraline in patients with mixed anxiety-depressive disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):75-84

Psychodermatological aspects of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):403-411

Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

Effects of corticosterone and antidepressants fluoxetine and amitriptyline on the expression of neurotrophic factors in rat astrocytoma C6 cells. Molecular Genetics, Microbiology and Virology. 2025;(4-2):111-120

Psychotherapeutic component in the treatment of acute and prevention of chronic postoperative pain. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):44-49

Transcranial electrostimulation as part of combination therapy for mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):37-44

Abstract:

This paper presents a case report of a patient with neurotic depression. The features of personal predisposition and clinical characteristics of the disease are considered. The authors note the advantages of an integrated approach to the treatment of neurotic depression with antidepressants and psychotherapy (cognitive behavioral therapy).

Keywords:

neurotic depression

antidepressants

cognitive behavioral therapy

vortioxetine

Authors:

Volel' B.A.

Pervyĭ MGMU im. I.M. Sechenova Minzdrava Rossii, Moskva

Sorokina O.Yu.

Mental Health Research Center, Moscow, Russia

Close metadata

References:

Jacobi F, Wittchen H-U, Hölting C, Höfler M, Pfister H, Müller N, Lieb R. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34(4):597-611. https://doi.org/10.1017/s0033291703001399
Ohayon MM. Epidemiology of depression and its treatment in general population. J Psychiatr Res. 2007;41(3-4):207-213. https://doi.org/10.1016/j.jpsychires.2006.10.006
Melnikov AI, Smekalkina LV. Modern approaches to non-drug methods in regenerative treatment of neurotic depression. Valeologiya. 2014;1:25-30. (In Russ.)
Vasileva AV, Karavaeva TA, Poltorak SV. Lingering forms of neurotic disorders: clinical-psychopathological aspects and therapy issues. Obozrenie Psikhiatrii i Meditsinskoi Psikhologii. 2012;4:81-87. (In Russ.)
Poltorak SV, Vasilyeva AV. Psychodynamic Aspects of Psychotherapeutic and Pharmacological Treatment of Neurotic Disorders. Obozrenie Psikhiatrii i Meditsinskoi Psikhologii. 2012;3:88-92. (In Russ.)
Smulevich AB. Depression in psychiatric and medical practices. M.: Medical informational agency; 2015. (In Russ.)
Voronova EI, Romanov DV. K epidemiologicheskoi kharakteristike psikhogennykh depressii. Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. 2015;2:49-52. (In Russ.)
Avedisova AS. Remissiya pri terapii antidepressantami: priznak stabilizatsii sostoyaniya ili priznak snizheniya aktivnosti protsessa? Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. 2008;10(2):33-37. (In Russ.)
Mosolov SN. Rezistentnost’ k psikhofarmakoterapii i metody ee preodoleniya. Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. 2002;4(4):132-136. (In Russ.)
Brown WA. Treatment response in melancholia. Acta Psyhiat Scand. 2007; 115(suppl 433):125-129. https://doi.org/10.1111/j.1600-0447.2007.00970.x
Shmunk EV. Faktory, okazyvayushchie vliyanie na kliniku i techenie depressivnykh rasstroistv. Sotsialnaya i Klinicheskaya Psikhiatriya. 2009;2:87-92. (In Russ.)
Bardenshtein LM. Sovremennye podkhody k terapii depressii. Rossiiskii Meditsinskii Zhurnal. 2010;5:28-30. (In Russ.)
Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry. 1998;59(12):669-675. https://doi.org/10.4088/jcp.v59n1205
Angst J. Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry. 1999;60(6):5-9.
Gormley N, O’Leary D. Time to remission in major depression. Is there a link between ‘no-treatment interval’ and outcome? Eur Psychiatry. 1996;11(4):290-291. https://doi.org/10.1016/0924-9338(96)88885-7
Avedisova AS, Borodin VI, Akhapkin RV. Analiz prediktorov perenosimosti timoanalepticheskoi terapii. Rossiiskii Psikhiatricheskii Zhurnal. 2004;5:24-29. (In Russ.)
Manicavasagar V, Silove D, Wagner R, Hadzi-Pavlovic D. Parental representations associated with adult separation anxiety and panic disorder-agoraphobia. Australian and New Zealand Journal of Psychiatry. 1999;33(3):422-428. https://doi.org/10.1046/j.1440-1614.1999.00566.x
Varga AYa. Vvedenie v sistemnuyu semeinuyu psikhoterapiyu. M.: Kogito-Tsentr; 2009. (In Russ.)
Volel BA, Petelin DS, Akhapkin RV, Malyutina AA. Cognitive impairment in anxiety disorders. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2018;10(1):78-82 (In Russ.) https://doi.org/10.14412/2074-2711-2018-1-78-82
Lakosina ND, Trunova MM. Nevrozy, nevroticheskie razvitiya lichnosti i psikhopatii: klinika i lechenie. M.: Meditsina; 1994. (In Russ.)
Roth M, Mountjoy CQ. The need for the concept of neurotic depression. In: H.S. Akiskal, G.B. Cassano, eds. Dysthymia and the spectrum of chronic depressions. New York: Guilford press; 1997.
Wang J, Liu XF, Feng C, Bao Q, Fu HR. Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study. Int J Psychiatry Clin Pract. 2017;7:1-6. https://doi.org/10.1080/13651501.2017.1397700
Christensen MC, Loft H, McIntyre RS. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders. J Affect Disord. 2018;227:787-794. https://doi.org/10.1016/j.jad.2017.11.081
Gonda X, Sharma SR, Tarazi FI. Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. Expert Opin Drug Discov. 2018;20:1-9. https://doi.org/10.1080/17460441.2019.1546691
Baldwin R, Florea I, Jacobsen PL, Zhong W, Nomikos GG. A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms. J Affect Disord. 2016;206:140-150. https://doi.org/10.1016/j.jad.2016.07.015
McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials. Int J Neuropsychopharmacol. 2016;19(10):1-9. https://doi.org/10.1093/ijnp/pyw055

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.